Ding X, Yin X, Zheng L, Zhou L, Hu J, Sun W, et al. Patients with uHCC and Child-Pugh B8/9 also benefit from a combination of antiangiogenic agents and PD-1 inhibitors: a multicenter real-world study. AO [Internet]. 2025 May 5 [cited 2026 May 13];64:607-15. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/42652